Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
R&D channel feed
Moderna, facing revenue misses and political headwinds, disappoints Wall Street
5 weeks ago
Pharma
CROs raise the alarm as clients delay R&D plans over funding, tariff worries
5 weeks ago
Outsourcing
Moderna expands effort to rein in costs in an ‘uncertain environment’
5 weeks ago
Pharma
Scientists alarmed about future of cancer research; TIGIT, CAR-NK and more from #AACR25
Last month
Artios drug exploits ‘replication stress’ in cancer, shrinking subset of tumors in early study
Last month
Startups
Novartis continues earnings winning streak as it raises 2025 sales expectations
Last month
Pharma
Boehringer’s updated results in HER2-mutated lung cancer impress
Last month
GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer
Last month
Pharma
Keytruda around head and neck cancer surgery cuts chance of disease coming back
Last month
Revolution Medicines' KRAS drug shows potential in early cut of lung cancer data
Last month
J&J reports durability data for bladder cancer 'pretzel' drug after FDA filing
Last month
FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill
Last month
Pharma
FDA+
Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval
Last month
China
Hoping to turn CD47 around with Keytruda combo, ALX Oncology reports two Phase 2 failures
Last month
Caribou lays off 32% of staff, cuts lupus cell therapy program before first patient
Last month
People
Cell/Gene Tx
Sanofi's Altuviiio closing in on blockbuster status, Dupixent sales surge
Last month
Pharma
Ascletis posts puzzling Phase 1 update on obesity pill
Last month
Akeso reports another Phase 3 win for PD-1xVEGF approach in lung cancer
Last month
Boehringer taps Dutch biotech for ALT positive cancer pact exceeding $573M in biobucks
Last month
Deals
Bristol Myers' schizophrenia drug fails Phase 3 trial for adjunctive treatment
Last month
Pharma
AstraZeneca, Daiichi eye first-line breast cancer market after Enhertu's early Phase 3 win
Last month
Pharma
China startup injects CRISPR therapy into the brain for the first time
Last month
Startups
China
Trodelvy and Keytruda combo succeeds in Phase 3 breast cancer study
Last month
Roivant brings rare disease program closer as Immunovant CEO retires
Last month
People
First page
Previous page
1
2
3
4
5
6
7
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit